• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估AURKA-HMMR-TPX2-TUBG1功能模块与BRCA1/2突变携带者患乳腺癌风险之间的关联。

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.

作者信息

Blanco Ignacio, Kuchenbaecker Karoline, Cuadras Daniel, Wang Xianshu, Barrowdale Daniel, de Garibay Gorka Ruiz, Librado Pablo, Sánchez-Gracia Alejandro, Rozas Julio, Bonifaci Núria, McGuffog Lesley, Pankratz Vernon S, Islam Abul, Mateo Francesca, Berenguer Antoni, Petit Anna, Català Isabel, Brunet Joan, Feliubadaló Lidia, Tornero Eva, Benítez Javier, Osorio Ana, Ramón y Cajal Teresa, Nevanlinna Heli, Aittomäki Kristiina, Arun Banu K, Toland Amanda E, Karlan Beth Y, Walsh Christine, Lester Jenny, Greene Mark H, Mai Phuong L, Nussbaum Robert L, Andrulis Irene L, Domchek Susan M, Nathanson Katherine L, Rebbeck Timothy R, Barkardottir Rosa B, Jakubowska Anna, Lubinski Jan, Durda Katarzyna, Jaworska-Bieniek Katarzyna, Claes Kathleen, Van Maerken Tom, Díez Orland, Hansen Thomas V, Jønson Lars, Gerdes Anne-Marie, Ejlertsen Bent, de la Hoya Miguel, Caldés Trinidad, Dunning Alison M, Oliver Clare, Fineberg Elena, Cook Margaret, Peock Susan, McCann Emma, Murray Alex, Jacobs Chris, Pichert Gabriella, Lalloo Fiona, Chu Carol, Dorkins Huw, Paterson Joan, Ong Kai-Ren, Teixeira Manuel R, Hogervorst Frans B L, van der Hout Annemarie H, Seynaeve Caroline, van der Luijt Rob B, Ligtenberg Marjolijn J L, Devilee Peter, Wijnen Juul T, Rookus Matti A, Meijers-Heijboer Hanne E J, Blok Marinus J, van den Ouweland Ans M W, Aalfs Cora M, Rodriguez Gustavo C, Phillips Kelly-Anne A, Piedmonte Marion, Nerenstone Stacy R, Bae-Jump Victoria L, O'Malley David M, Ratner Elena S, Schmutzler Rita K, Wappenschmidt Barbara, Rhiem Kerstin, Engel Christoph, Meindl Alfons, Ditsch Nina, Arnold Norbert, Plendl Hansjoerg J, Niederacher Dieter, Sutter Christian, Wang-Gohrke Shan, Steinemann Doris, Preisler-Adams Sabine, Kast Karin, Varon-Mateeva Raymonda, Gehrig Andrea, Bojesen Anders, Pedersen Inge Sokilde, Sunde Lone, Jensen Uffe Birk, Thomassen Mads, Kruse Torben A, Foretova Lenka, Peterlongo Paolo, Bernard Loris, Peissel Bernard, Scuvera Giulietta, Manoukian Siranoush, Radice Paolo, Ottini Laura, Montagna Marco, Agata Simona, Maugard Christine, Simard Jacques, Soucy Penny, Berger Andreas, Fink-Retter Anneliese, Singer Christian F, Rappaport Christine, Geschwantler-Kaulich Daphne, Tea Muy-Kheng, Pfeiler Georg, John Esther M, Miron Alex, Neuhausen Susan L, Terry Mary Beth, Chung Wendy K, Daly Mary B, Goldgar David E, Janavicius Ramunas, Dorfling Cecilia M, van Rensburg Elisabeth J, Fostira Florentia, Konstantopoulou Irene, Garber Judy, Godwin Andrew K, Olah Edith, Narod Steven A, Rennert Gad, Paluch Shani Shimon, Laitman Yael, Friedman Eitan, Liljegren Annelie, Rantala Johanna, Stenmark-Askmalm Marie, Loman Niklas, Imyanitov Evgeny N, Hamann Ute, Spurdle Amanda B, Healey Sue, Weitzel Jeffrey N, Herzog Josef, Margileth David, Gorrini Chiara, Esteller Manel, Gómez Antonio, Sayols Sergi, Vidal Enrique, Heyn Holger, Stoppa-Lyonnet Dominique, Léoné Melanie, Barjhoux Laure, Fassy-Colcombet Marion, de Pauw Antoine, Lasset Christine, Ferrer Sandra Fert, Castera Laurent, Berthet Pascaline, Cornelis François, Bignon Yves-Jean, Damiola Francesca, Mazoyer Sylvie, Sinilnikova Olga M, Maxwell Christopher A, Vijai Joseph, Robson Mark, Kauff Noah, Corines Marina J, Villano Danylko, Cunningham Julie, Lee Adam, Lindor Noralane, Lázaro Conxi, Easton Douglas F, Offit Kenneth, Chenevix-Trench Georgia, Couch Fergus J, Antoniou Antonis C, Pujana Miguel Angel

机构信息

Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.

Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.

出版信息

PLoS One. 2015 Apr 1;10(4):e0120020. doi: 10.1371/journal.pone.0120020. eCollection 2015.

DOI:10.1371/journal.pone.0120020
PMID:25830658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4382299/
Abstract

While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04-1.15, p = 1.9 x 10(-4) (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03-1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted pinteraction values > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.

摘要

虽然BRCA1与AURKA-RHAMM-TPX2-TUBG1之间的相互作用调节乳腺上皮细胞极化,但HMMR(基因产物RHAMM)的常见基因变异可能与BRCA1突变携带者患乳腺癌的风险相关。基于这些观察结果,我们进一步评估了AURKA-HMMR-TPX2-TUBG1功能模块与BRCA1或BRCA2突变携带者患乳腺癌风险之间的联系。对15252名BRCA1突变携带者和8211名BRCA2突变携带者的41个单核苷酸多态性(SNP)进行了基因分型,随后采用回顾性似然法进行分析。BRCA1突变携带者中HMMR rs299290与乳腺癌风险的关联得到证实:每等位基因风险比(HR)=1.10,95%置信区间(CI)1.04-1.15,p = 1.9×10⁻⁴(错误发现率(FDR)调整后p = 0.043)。还发现位于AURKA旁边的CSTF1变异与BRCA2突变携带者患乳腺癌的风险相关:rs2426618每等位基因HR = 1.10,95%CI 1.03-1.16,p = 0.005(FDR调整后p = 0.045)。对成对相互作用的评估为BRCA1和BRCA2突变携带者中rs299290与CSTF1 rs6064391以及rs299290与TUBG1 rs11649877偏离乘法模型提供了提示(FDR调整后p相互作用值>0.05)。遵循这些提示,发现散发性乳腺肿瘤中HMMR与AURKA或TUBG1的表达可能相互作用,影响患者的生存。总之,本研究结果支持AURKA-HMMR-TPX2-TUBG1功能改变与BRCA1/2突变携带者乳腺癌发生之间存在因果联系的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/8d6c7548eb68/pone.0120020.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/3855d26be016/pone.0120020.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/93194598c9cf/pone.0120020.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/10898638a458/pone.0120020.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/8d6c7548eb68/pone.0120020.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/3855d26be016/pone.0120020.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/93194598c9cf/pone.0120020.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/10898638a458/pone.0120020.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef6/4382299/8d6c7548eb68/pone.0120020.g004.jpg

相似文献

1
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.评估AURKA-HMMR-TPX2-TUBG1功能模块与BRCA1/2突变携带者患乳腺癌风险之间的关联。
PLoS One. 2015 Apr 1;10(4):e0120020. doi: 10.1371/journal.pone.0120020. eCollection 2015.
2
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.BRCA1 和 RHAMM 之间的相互作用调节上皮细胞的顶底极性,可能会影响乳腺癌的风险。
PLoS Biol. 2011 Nov;9(11):e1001199. doi: 10.1371/journal.pbio.1001199. Epub 2011 Nov 15.
3
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.BRCA1和BRCA2突变携带者中AURKA F31I多态性与乳腺癌风险:BRCA1/2修饰因子研究调查员联盟
Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1416-21. doi: 10.1158/1055-9965.EPI-07-0129.
4
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.常见的乳腺癌易感等位基因与BRCA1和BRCA2突变携带者的乳腺癌风险相关。
Am J Hum Genet. 2008 Apr;82(4):937-48. doi: 10.1016/j.ajhg.2008.02.008. Epub 2008 Mar 20.
5
Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.HMMR/RHAMM的基因组失衡调节恶性外周神经鞘膜瘤细胞对极光激酶抑制的敏感性和反应。
Oncotarget. 2013 Jan;4(1):80-93. doi: 10.18632/oncotarget.793.
6
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.全基因组关联研究中与乳腺癌相关的常见变异是 BRCA1 和 BRCA2 突变携带者乳腺癌风险的修饰因子。
Hum Mol Genet. 2010 Jul 15;19(14):2886-97. doi: 10.1093/hmg/ddq174. Epub 2010 Apr 23.
7
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.常见的乳腺癌易感等位基因与 BRCA1 和 BRCA2 突变携带者的肿瘤亚型相关:BRCA1/2 修饰因子研究人员联盟的研究结果。
Breast Cancer Res. 2011;13(6):R110. doi: 10.1186/bcr3052. Epub 2011 Nov 2.
8
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.TP53基因第72位密码子精氨酸突变为脯氨酸以及MDM2基因第309位密码子鸟嘌呤突变为胸腺嘧啶这两个多态性与携带BRCA1和BRCA2基因突变的女性患乳腺癌风险无关。
Br J Cancer. 2009 Oct 20;101(8):1456-60. doi: 10.1038/sj.bjc.6605279. Epub 2009 Aug 25.
9
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.没有证据表明CDKN1B(p27)基因多态性会改变BRCA1和BRCA2突变携带者患乳腺癌的风险。
Breast Cancer Res Treat. 2009 May;115(2):307-13. doi: 10.1007/s10549-008-0083-5. Epub 2008 Jun 10.
10
The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.ITGB3 基因中的 Leu33Pro 多态性不会改变 BRCA1/2 相关的乳腺癌或卵巢癌风险:来自 15542 名 BRCA1 和 BRCA2 突变携带者的多中心研究结果。
Breast Cancer Res Treat. 2010 Jun;121(3):639-49. doi: 10.1007/s10549-009-0595-7. Epub 2009 Oct 30.

引用本文的文献

1
Targeting RHAMM in Cancer: Crosstalk with Non-Coding RNAs and Emerging Therapeutic Strategies Including Peptides, Oligomers, Antibodies, and Vaccines.癌症中靶向透明质酸介导的运动受体(RHAMM):与非编码RNA的相互作用及新兴治疗策略,包括肽、寡聚物、抗体和疫苗
Int J Mol Sci. 2025 Jul 25;26(15):7198. doi: 10.3390/ijms26157198.
2
Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations.靶向极光激酶A和聚(ADP - 核糖)聚合酶作为卵巢癌患者的一种治疗选择:临床前评估
J Cancer Res Clin Oncol. 2025 Mar 26;151(3):124. doi: 10.1007/s00432-025-06152-7.
3

本文引用的文献

1
Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage.系统筛查揭示了 BRCA1 在转录相关的 DNA 损伤反应中的作用。
Genes Dev. 2014 Sep 1;28(17):1957-75. doi: 10.1101/gad.241620.114.
2
The Naked Mole Rat Genome Resource: facilitating analyses of cancer and longevity-related adaptations.裸鼹鼠基因组资源:促进癌症和长寿相关适应性分析。
Bioinformatics. 2014 Dec 15;30(24):3558-60. doi: 10.1093/bioinformatics/btu579. Epub 2014 Aug 28.
3
OrthoMaM v8: a database of orthologous exons and coding sequences for comparative genomics in mammals.
Mitotic kinases are emerging therapeutic targets against metastatic breast cancer.
有丝分裂激酶正在成为抗转移性乳腺癌的治疗靶点。
Cell Div. 2024 Jun 17;19(1):21. doi: 10.1186/s13008-024-00125-x.
4
Upregulation of TUBG1 expression promotes hepatocellular carcinoma development.TUBG1 表达上调促进肝癌发展。
Med Oncol. 2023 Feb 15;40(3):96. doi: 10.1007/s12032-023-01966-2.
5
Gene co-expression analyses of health(span) across multiple species.跨多个物种的健康(寿命)基因共表达分析。
NAR Genom Bioinform. 2022 Nov 29;4(4):lqac083. doi: 10.1093/nargab/lqac083. eCollection 2022 Dec.
6
Hyaluronan Receptors as Mediators and Modulators of the Tumor Microenvironment.透明质酸受体作为肿瘤微环境的介质和调节剂。
Adv Healthc Mater. 2023 Feb;12(5):e2202118. doi: 10.1002/adhm.202202118. Epub 2022 Nov 28.
7
Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病和肝细胞癌共同致病基因的筛查
Front Oncol. 2022 Aug 11;12:911808. doi: 10.3389/fonc.2022.911808. eCollection 2022.
8
The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities.RHAMM在癌症中的作用:揭示新的治疗靶点。
Front Oncol. 2022 Aug 10;12:982231. doi: 10.3389/fonc.2022.982231. eCollection 2022.
9
Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.黑色素瘤中异常甲基化的差异表达基因的鉴定及KIF2C的促肿瘤作用
Front Genet. 2022 Jul 22;13:817656. doi: 10.3389/fgene.2022.817656. eCollection 2022.
10
Bioinformatics role of the WGCNA analysis and co-expression network identifies of prognostic marker in lung cancer.加权基因共表达网络分析(WGCNA)的生物信息学作用及肺癌预后标志物的共表达网络鉴定
Saudi J Biol Sci. 2022 May;29(5):3519-3527. doi: 10.1016/j.sjbs.2022.02.016. Epub 2022 Feb 23.
OrthoMaM v8:哺乳动物比较基因组学中同源外显子和编码序列的数据库。
Mol Biol Evol. 2014 Jul;31(7):1923-8. doi: 10.1093/molbev/msu132. Epub 2014 Apr 9.
4
Integrating gene expression and epidemiological data for the discovery of genetic interactions associated with cancer risk.整合基因表达和流行病学数据,以发现与癌症风险相关的遗传相互作用。
Carcinogenesis. 2014 Mar;35(3):578-85. doi: 10.1093/carcin/bgt403. Epub 2013 Dec 2.
5
Comprehensive functional annotation of seventy-one breast cancer risk Loci.综合注释 71 个乳腺癌风险基因座。
PLoS One. 2013 May 22;8(5):e63925. doi: 10.1371/journal.pone.0063925. Print 2013.
6
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.BRCA1 突变携带者的全基因组关联研究确定了与乳腺癌和卵巢癌风险相关的新位点。
PLoS Genet. 2013;9(3):e1003212. doi: 10.1371/journal.pgen.1003212. Epub 2013 Mar 27.
7
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.鉴定与乳腺癌风险相关的位于 6p24 的 BRCA2 特异性修饰基因座。
PLoS Genet. 2013;9(3):e1003173. doi: 10.1371/journal.pgen.1003173. Epub 2013 Mar 27.
8
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.利用 iCOGS 定制基因分型阵列鉴定 23 个新的前列腺癌易感性位点。
Nat Genet. 2013 Apr;45(4):385-91, 391e1-2. doi: 10.1038/ng.2560.
9
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.GWAS 荟萃分析和复制确定了三个新的卵巢癌易感性位点。
Nat Genet. 2013 Apr;45(4):362-70, 370e1-2. doi: 10.1038/ng.2564.
10
Large-scale genotyping identifies 41 new loci associated with breast cancer risk.大规模基因分型鉴定出 41 个与乳腺癌风险相关的新位点。
Nat Genet. 2013 Apr;45(4):353-61, 361e1-2. doi: 10.1038/ng.2563.